Galbato Chan

October 10, 2026

Eastern Company Backlog Growth Faces Skepticism. Recent analysis questions whether The Eastern Company's growing backlog is sufficient to support current optimism. While the firm reports increased order volume, some observers argue this may not fully justify the stock's valuation. The company trades with a trailing P/E of 19.2 and a dividend yield of 2.42%.

September 30, 2026

Accuray (ARAY) noted among health‑care stocks moving in recent sessions. Accuray appeared in several recent lists of health‑care stocks showing price movement in pre‑market, after‑market and intraday sessions. The activity comes as the stock trades near its $0.25 support level with an RSI around 58, suggesting modest momentum. Analysts have an average target of $0.35, above the current price.

October 8, 2026

ACI Faces Q2 Sales Pressure Amid Store Closures. Albertsons is expected to report second-quarter results below analyst consensus, with RBC noting a larger-than-expected decline in identical sales. The company continues to close stores at a recently acquired chain while facing price competition from Walmart. UBS highlights potential upside from its ACI Edge program despite near-term grocery challenges.

October 16, 2026

Blue Bird Lays Out Stock Market Strategy, Analysts Optimistic. Blue Bird Laps the Stock Market with a new strategy, drawing analyst optimism. The company partnered with LightSource to centralize supply‑chain data, cutting sourcing decision time by two days. With a trailing P/E of 6.4 and a target range of $82‑$95, the stock sits near its 52‑week low but could benefit from the operational efficiencies.